APO Research
Talk to an analyst

APO RESEARCH · REPORT

High Affinity Nerve Growth Factor Receptor

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global High Affinity Nerve Growth Factor Receptor Industry Growth and Trends Forecast to 2032

19 December 2025113 pages

Choose your research edition.

Industry ResearchHigh Affinity Nerve Growth Factor Receptor Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal High Affinity Nerve Growth Factor Receptor Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal High Affinity Nerve Growth Factor Receptor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal High Affinity Nerve Growth Factor Receptor Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal High Affinity Nerve Growth Factor Receptor Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

According to APO Research, the global High Affinity Nerve Growth Factor Receptor market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for High Affinity Nerve Growth Factor Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for High Affinity Nerve Growth Factor Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for High Affinity Nerve Growth Factor Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the High Affinity Nerve Growth Factor Receptor market include Merck & Co Inc, AstraZeneca Plc, Tiziana Life Sciences Plc, Sienna Biopharmaceuticals Inc, Rottapharm Biotech Srl, Proximagen Ltd, Plexxikon Inc, Nerviano Medical Sciences Srl and Loxo Oncology Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global High Affinity Nerve Growth Factor Receptor market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The High Affinity Nerve Growth Factor Receptor market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global High Affinity Nerve Growth Factor Receptor market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to High Affinity Nerve Growth Factor Receptor.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global High Affinity Nerve Growth Factor Receptor market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

High Affinity Nerve Growth Factor Receptor Market by Company

Merck & Co Inc

AstraZeneca Plc

Tiziana Life Sciences Plc

Sienna Biopharmaceuticals Inc

Rottapharm Biotech Srl

Proximagen Ltd

Plexxikon Inc

Nerviano Medical Sciences Srl

Loxo Oncology Inc

Ignyta Inc

Handok Inc

Genzyme Corp

Dompe Farmaceutici SpA

Daiichi Sankyo Co Ltd

Astellas Pharma Inc

Array BioPharma Inc

High Affinity Nerve Growth Factor Receptor Segment by Type

Cenegermin

CRB-0089

BNN-27

AZD-7451

ASP-7962

Others

High Affinity Nerve Growth Factor Receptor Segment by Application

Low Back Pain

Papillary Thyroid Cancer

Lung Cancer

Bile Duct Cancer

Others

High Affinity Nerve Growth Factor Receptor Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global High Affinity Nerve Growth Factor Receptor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of High Affinity Nerve Growth Factor Receptor and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of High Affinity Nerve Growth Factor Receptor.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of High Affinity Nerve Growth Factor Receptor companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global High Affinity Nerve Growth Factor Receptor Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global High Affinity Nerve Growth Factor Receptor Market Size by Region (2021-2026) & (US$ Million) Table 3. Global High Affinity Nerve Growth Factor Receptor Market Share by Region (2021-2026) Table 4. Global High Affinity Nerve Growth Factor Receptor Market Size by Region (2027-2032) & (US$ Million) Table 5. Global High Affinity Nerve Growth Factor Receptor Market Share by Region (2027-2032) Table 6. Global High Affinity Nerve Growth Factor Receptor Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global High Affinity Nerve Growth Factor Receptor Market Size by Type (2021-2026) & (US$ Million) Table 8. Global High Affinity Nerve Growth Factor Receptor Market Size Share by Type (2021-2026) Table 9. Global High Affinity Nerve Growth Factor Receptor Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global High Affinity Nerve Growth Factor Receptor Market Size Share Forecasted by Type (2027-2032) Table 11. North America High Affinity Nerve Growth Factor Receptor Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America High Affinity Nerve Growth Factor Receptor Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe High Affinity Nerve Growth Factor Receptor Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe High Affinity Nerve Growth Factor Receptor Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America High Affinity Nerve Growth Factor Receptor Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America High Affinity Nerve Growth Factor Receptor Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa High Affinity Nerve Growth Factor Receptor Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa High Affinity Nerve Growth Factor Receptor Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global High Affinity Nerve Growth Factor Receptor Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global High Affinity Nerve Growth Factor Receptor Market Size by Application (2021-2026) & (US$ Million) Table 23. Global High Affinity Nerve Growth Factor Receptor Market Size Share by Application (2021-2026) Table 24. Global High Affinity Nerve Growth Factor Receptor Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global High Affinity Nerve Growth Factor Receptor Market Size Share Forecasted by Application (2027-2032) Table 26. North America High Affinity Nerve Growth Factor Receptor Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America High Affinity Nerve Growth Factor Receptor Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe High Affinity Nerve Growth Factor Receptor Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe High Affinity Nerve Growth Factor Receptor Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America High Affinity Nerve Growth Factor Receptor Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America High Affinity Nerve Growth Factor Receptor Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa High Affinity Nerve Growth Factor Receptor Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa High Affinity Nerve Growth Factor Receptor Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. High Affinity Nerve Growth Factor Receptor Industry Trends Table 37. High Affinity Nerve Growth Factor Receptor Industry Drivers Table 38. High Affinity Nerve Growth Factor Receptor Industry Opportunities and Challenges Table 39. High Affinity Nerve Growth Factor Receptor Industry Restraints Table 40. Global High Affinity Nerve Growth Factor Receptor Revenue by Company (US$ Million) & (2021-2026) Table 41. Global High Affinity Nerve Growth Factor Receptor Revenue Market Share by Company (2021-2026) Table 42. Global High Affinity Nerve Growth Factor Receptor Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global High Affinity Nerve Growth Factor Receptor Key Company Headquarters & Area Served Table 44. Global High Affinity Nerve Growth Factor Receptor Company, Product Type & Application Table 45. Global High Affinity Nerve Growth Factor Receptor Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global High Affinity Nerve Growth Factor Receptor by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Merck & Co Inc Company Information Table 49. Merck & Co Inc Business Overview Table 50. Merck & Co Inc High Affinity Nerve Growth Factor Receptor Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Merck & Co Inc High Affinity Nerve Growth Factor Receptor Product Portfolio Table 52. Merck & Co Inc Recent Development Table 53. AstraZeneca Plc Company Information Table 54. AstraZeneca Plc Business Overview Table 55. AstraZeneca Plc High Affinity Nerve Growth Factor Receptor Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. AstraZeneca Plc High Affinity Nerve Growth Factor Receptor Product Portfolio Table 57. AstraZeneca Plc Recent Development Table 58. Tiziana Life Sciences Plc Company Information Table 59. Tiziana Life Sciences Plc Business Overview Table 60. Tiziana Life Sciences Plc High Affinity Nerve Growth Factor Receptor Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Tiziana Life Sciences Plc High Affinity Nerve Growth Factor Receptor Product Portfolio Table 62. Tiziana Life Sciences Plc Recent Development Table 63. Sienna Biopharmaceuticals Inc Company Information Table 64. Sienna Biopharmaceuticals Inc Business Overview Table 65. Sienna Biopharmaceuticals Inc High Affinity Nerve Growth Factor Receptor Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Sienna Biopharmaceuticals Inc High Affinity Nerve Growth Factor Receptor Product Portfolio Table 67. Sienna Biopharmaceuticals Inc Recent Development Table 68. Rottapharm Biotech Srl Company Information Table 69. Rottapharm Biotech Srl Business Overview Table 70. Rottapharm Biotech Srl High Affinity Nerve Growth Factor Receptor Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Rottapharm Biotech Srl High Affinity Nerve Growth Factor Receptor Product Portfolio Table 72. Rottapharm Biotech Srl Recent Development Table 73. Proximagen Ltd Company Information Table 74. Proximagen Ltd Business Overview Table 75. Proximagen Ltd High Affinity Nerve Growth Factor Receptor Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Proximagen Ltd High Affinity Nerve Growth Factor Receptor Product Portfolio Table 77. Proximagen Ltd Recent Development Table 78. Plexxikon Inc Company Information Table 79. Plexxikon Inc Business Overview Table 80. Plexxikon Inc High Affinity Nerve Growth Factor Receptor Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Plexxikon Inc High Affinity Nerve Growth Factor Receptor Product Portfolio Table 82. Plexxikon Inc Recent Development Table 83. Nerviano Medical Sciences Srl Company Information Table 84. Nerviano Medical Sciences Srl Business Overview Table 85. Nerviano Medical Sciences Srl High Affinity Nerve Growth Factor Receptor Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Nerviano Medical Sciences Srl High Affinity Nerve Growth Factor Receptor Product Portfolio Table 87. Nerviano Medical Sciences Srl Recent Development Table 88. Loxo Oncology Inc Company Information Table 89. Loxo Oncology Inc Business Overview Table 90. Loxo Oncology Inc High Affinity Nerve Growth Factor Receptor Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Loxo Oncology Inc High Affinity Nerve Growth Factor Receptor Product Portfolio Table 92. Loxo Oncology Inc Recent Development Table 93. Ignyta Inc Company Information Table 94. Ignyta Inc Business Overview Table 95. Ignyta Inc High Affinity Nerve Growth Factor Receptor Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Ignyta Inc High Affinity Nerve Growth Factor Receptor Product Portfolio Table 97. Ignyta Inc Recent Development Table 98. Handok Inc Company Information Table 99. Handok Inc Business Overview Table 100. Handok Inc High Affinity Nerve Growth Factor Receptor Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Handok Inc High Affinity Nerve Growth Factor Receptor Product Portfolio Table 102. Handok Inc Recent Development Table 103. Genzyme Corp Company Information Table 104. Genzyme Corp Business Overview Table 105. Genzyme Corp High Affinity Nerve Growth Factor Receptor Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Genzyme Corp High Affinity Nerve Growth Factor Receptor Product Portfolio Table 107. Genzyme Corp Recent Development Table 108. Dompe Farmaceutici SpA Company Information Table 109. Dompe Farmaceutici SpA Business Overview Table 110. Dompe Farmaceutici SpA High Affinity Nerve Growth Factor Receptor Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Dompe Farmaceutici SpA High Affinity Nerve Growth Factor Receptor Product Portfolio Table 112. Dompe Farmaceutici SpA Recent Development Table 113. Daiichi Sankyo Co Ltd Company Information Table 114. Daiichi Sankyo Co Ltd Business Overview Table 115. Daiichi Sankyo Co Ltd High Affinity Nerve Growth Factor Receptor Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Daiichi Sankyo Co Ltd High Affinity Nerve Growth Factor Receptor Product Portfolio Table 117. Daiichi Sankyo Co Ltd Recent Development Table 118. Astellas Pharma Inc Company Information Table 119. Astellas Pharma Inc Business Overview Table 120. Astellas Pharma Inc High Affinity Nerve Growth Factor Receptor Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Astellas Pharma Inc High Affinity Nerve Growth Factor Receptor Product Portfolio Table 122. Astellas Pharma Inc Recent Development Table 123. Array BioPharma Inc Company Information Table 124. Array BioPharma Inc Business Overview Table 125. Array BioPharma Inc High Affinity Nerve Growth Factor Receptor Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Array BioPharma Inc High Affinity Nerve Growth Factor Receptor Product Portfolio Table 127. Array BioPharma Inc Recent Development Table 128. North America High Affinity Nerve Growth Factor Receptor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. North America High Affinity Nerve Growth Factor Receptor Market Size by Country (2021-2026) & (US$ Million) Table 130. North America High Affinity Nerve Growth Factor Receptor Market Share by Country (2021-2026) Table 131. North America High Affinity Nerve Growth Factor Receptor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. North America High Affinity Nerve Growth Factor Receptor Market Share Forecast by Country (2027-2032) Table 133. Europe High Affinity Nerve Growth Factor Receptor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Europe High Affinity Nerve Growth Factor Receptor Market Size by Country (2021-2026) & (US$ Million) Table 135. Europe High Affinity Nerve Growth Factor Receptor Market Share by Country (2021-2026) Table 136. Europe High Affinity Nerve Growth Factor Receptor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Europe High Affinity Nerve Growth Factor Receptor Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Size by Country (2021-2026) & (US$ Million) Table 140. Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Share by Country (2021-2026) Table 141. Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Share Forecast by Country (2027-2032) Table 143. Latin America High Affinity Nerve Growth Factor Receptor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Latin America High Affinity Nerve Growth Factor Receptor Market Size by Country (2021-2026) & (US$ Million) Table 145. Latin America High Affinity Nerve Growth Factor Receptor Market Share by Country (2021-2026) Table 146. Latin America High Affinity Nerve Growth Factor Receptor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Latin America High Affinity Nerve Growth Factor Receptor Market Share Forecast by Country (2027-2032) Table 148. Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size by Country (2021-2026) & (US$ Million) Table 150. Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Share by Country (2021-2026) Table 151. Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Share Forecast by Country (2027-2032) Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. High Affinity Nerve Growth Factor Receptor Product Image Figure 3. Global High Affinity Nerve Growth Factor Receptor Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global High Affinity Nerve Growth Factor Receptor Market Size (2021-2032) & (US$ Million) Figure 5. Global High Affinity Nerve Growth Factor Receptor Market Share by Region: 2025 VS 2032 Figure 6. Global High Affinity Nerve Growth Factor Receptor Market Share by Region (2021-2032) Figure 7. North America High Affinity Nerve Growth Factor Receptor Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe High Affinity Nerve Growth Factor Receptor Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America High Affinity Nerve Growth Factor Receptor Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Cenegermin Image Figure 13. Global Cenegermin Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. CRB-0089 Image Figure 15. Global CRB-0089 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. BNN-27 Image Figure 17. Global BNN-27 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. AZD-7451 Image Figure 19. Global AZD-7451 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. ASP-7962 Image Figure 21. Global ASP-7962 Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Others Image Figure 23. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 24. Global High Affinity Nerve Growth Factor Receptor Market Size Overview by Type (2021-2032) & (US$ Million) Figure 25. Global High Affinity Nerve Growth Factor Receptor Market Share by Type 2025 VS 2032 Figure 26. North America High Affinity Nerve Growth Factor Receptor Market Size Share by Type (2021-2032) Figure 27. Europe High Affinity Nerve Growth Factor Receptor Market Size Share by Type (2021-2032) Figure 28. Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Size Share by Type (2021-2032) Figure 29. Latin America High Affinity Nerve Growth Factor Receptor Market Size Share by Type (2021-2032) Figure 30. Middle East and Africa High Affinity Nerve Growth Factor Receptor Market Size Share by Type (2021-2032) Figure 31. Low Back Pain Image Figure 32. Global Low Back Pain Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Papillary Thyroid Cancer Image Figure 34. Global Papillary Thyroid Cancer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Lung Cancer Image Figure 36. Global Lung Cancer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Bile Duct Cancer Image Figure 38. Global Bile Duct Cancer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Others Image Figure 40. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. Global High Affinity Nerve Growth Factor Receptor Market Size Overview by Application (2021-2032) & (US$ Million) Figure 42. Global High Affinity Nerve Growth Factor Receptor Market Share by Application 2025 VS 2032 Figure 43. North America High Affinity Nerve Growth Factor Receptor Market Size Share by Application (2021-2032) Figure 44. Europe High Affinity Nerve Growth Factor Receptor Market Size Share by Application (2021-2032) Figure 45. Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Size Share by Application (2021-2032) Figure 46. Latin America High Affinity Nerve Growth Factor Receptor Market Size Share by Application (2021-2032) Figure 47. Middle East and Africa High Affinity Nerve Growth Factor Receptor Market Size Share by Application (2021-2032) Figure 48. Global Top 5 and 10 High Affinity Nerve Growth Factor Receptor Players Market Share by Revenue in 2025 Figure 49. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 50. North America High Affinity Nerve Growth Factor Receptor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. North America High Affinity Nerve Growth Factor Receptor Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. North America High Affinity Nerve Growth Factor Receptor Market Share by Country (2021-2032) Figure 53. Europe High Affinity Nerve Growth Factor Receptor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe High Affinity Nerve Growth Factor Receptor Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe High Affinity Nerve Growth Factor Receptor Market Share by Country (2021-2032) Figure 56. Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Share by Country (2021-2032) Figure 59. Latin America High Affinity Nerve Growth Factor Receptor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America High Affinity Nerve Growth Factor Receptor Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America High Affinity Nerve Growth Factor Receptor Market Share by Country (2021-2032) Figure 62. Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 63. Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Share by Country: 2021 VS 2025 VS 2032 Figure 64. Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Share by Country (2021-2032) Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Cenegermin
  • CRB-0089
  • BNN-27
  • AZD-7451
  • ASP-7962
  • Others
Applications
  • Low Back Pain
  • Papillary Thyroid Cancer
  • Lung Cancer
  • Bile Duct Cancer
  • Others
Companies covered
  • Merck & Co Inc
  • AstraZeneca Plc
  • Tiziana Life Sciences Plc
  • Sienna Biopharmaceuticals Inc
  • Rottapharm Biotech Srl
  • Proximagen Ltd
  • Plexxikon Inc
  • Nerviano Medical Sciences Srl
  • Loxo Oncology Inc
  • Ignyta Inc
  • Handok Inc
  • Genzyme Corp
  • Dompe Farmaceutici SpA
  • Daiichi Sankyo Co Ltd
  • Astellas Pharma Inc
  • Array BioPharma Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global High Affinity Nerve Growth Factor Receptor Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global High Affinity Nerve Growth Factor Receptor Market Size by Region (2021-2032)
  5. 1.4.1 Global High Affinity Nerve Growth Factor Receptor Market Size by Region (2021-2026)
  6. 1.4.2 Global High Affinity Nerve Growth Factor Receptor Market Size by Region (2027-2032)
  7. 1.5 Key Regions High Affinity Nerve Growth Factor Receptor Market Size (2021-2032)
  8. 1.5.1 North America High Affinity Nerve Growth Factor Receptor Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe High Affinity Nerve Growth Factor Receptor Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America High Affinity Nerve Growth Factor Receptor Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size Growth Rate (2021-2032)
2 High Affinity Nerve Growth Factor Receptor Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Cenegermin
  3. 2.1.2 CRB-0089
  4. 2.1.3 BNN-27
  5. 2.1.4 AZD-7451
  6. 2.1.5 ASP-7962
  7. 2.1.6 Others
  8. 2.2 Global High Affinity Nerve Growth Factor Receptor Market Size by Type
  9. 2.2.1 Global High Affinity Nerve Growth Factor Receptor Market Size Overview by Type (2021-2032)
  10. 2.2.2 Global High Affinity Nerve Growth Factor Receptor Historic Market Size Review by Type (2021-2026)
  11. 2.2.3 Global High Affinity Nerve Growth Factor Receptor Market Size Forecasted by Type (2027-2032)
  12. 2.3 Global High Affinity Nerve Growth Factor Receptor Market Size by Regions
  13. 2.3.1 North America High Affinity Nerve Growth Factor Receptor Market Size Breakdown by Type (2021-2026)
  14. 2.3.2 Europe High Affinity Nerve Growth Factor Receptor Market Size Breakdown by Type (2021-2026)
  15. 2.3.3 Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Size Breakdown by Type (2021-2026)
  16. 2.3.4 South America High Affinity Nerve Growth Factor Receptor Market Size Breakdown by Type (2021-2026)
  17. 2.3.5 Middle East and Africa High Affinity Nerve Growth Factor Receptor Market Size Breakdown by Type (2021-2026)
3 High Affinity Nerve Growth Factor Receptor Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Low Back Pain
  3. 3.1.2 Papillary Thyroid Cancer
  4. 3.1.3 Lung Cancer
  5. 3.1.4 Bile Duct Cancer
  6. 3.1.5 Others
  7. 3.2 Global High Affinity Nerve Growth Factor Receptor Market Size by Application
  8. 3.2.1 Global High Affinity Nerve Growth Factor Receptor Market Size Overview by Application (2021-2032)
  9. 3.2.2 Global High Affinity Nerve Growth Factor Receptor Historic Market Size Review by Application (2021-2026)
  10. 3.2.3 Global High Affinity Nerve Growth Factor Receptor Market Size Forecasted by Application (2027-2032)
  11. 3.3 Global High Affinity Nerve Growth Factor Receptor Market Size by Regions
  12. 3.3.1 North America High Affinity Nerve Growth Factor Receptor Market Size Breakdown by Application (2021-2026)
  13. 3.3.2 Europe High Affinity Nerve Growth Factor Receptor Market Size Breakdown by Application (2021-2026)
  14. 3.3.3 Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Size Breakdown by Application (2021-2026)
  15. 3.3.4 South America High Affinity Nerve Growth Factor Receptor Market Size Breakdown by Application (2021-2026)
  16. 3.3.5 Middle East and Africa High Affinity Nerve Growth Factor Receptor Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 High Affinity Nerve Growth Factor Receptor Industry Trends
  2. 4.2 High Affinity Nerve Growth Factor Receptor Industry Drivers
  3. 4.3 High Affinity Nerve Growth Factor Receptor Industry Opportunities and Challenges
  4. 4.4 High Affinity Nerve Growth Factor Receptor Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by High Affinity Nerve Growth Factor Receptor Revenue (2021-2026)
  2. 5.2 Global High Affinity Nerve Growth Factor Receptor Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global High Affinity Nerve Growth Factor Receptor Key Company Headquarters & Area Served
  4. 5.4 Global High Affinity Nerve Growth Factor Receptor Company, Product Type & Application
  5. 5.5 Global High Affinity Nerve Growth Factor Receptor Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global High Affinity Nerve Growth Factor Receptor Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 High Affinity Nerve Growth Factor Receptor Players Market Share by Revenue in 2025
  9. 5.6.3 2025 High Affinity Nerve Growth Factor Receptor Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Merck & Co Inc
  2. 6.1.1 Merck & Co Inc Company Information
  3. 6.1.2 Merck & Co Inc Business Overview
  4. 6.1.3 Merck & Co Inc High Affinity Nerve Growth Factor Receptor Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Merck & Co Inc High Affinity Nerve Growth Factor Receptor Product Portfolio
  6. 6.1.5 Merck & Co Inc Recent Developments
  7. 6.2 AstraZeneca Plc
  8. 6.2.1 AstraZeneca Plc Company Information
  9. 6.2.2 AstraZeneca Plc Business Overview
  10. 6.2.3 AstraZeneca Plc High Affinity Nerve Growth Factor Receptor Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 AstraZeneca Plc High Affinity Nerve Growth Factor Receptor Product Portfolio
  12. 6.2.5 AstraZeneca Plc Recent Developments
  13. 6.3 Tiziana Life Sciences Plc
  14. 6.3.1 Tiziana Life Sciences Plc Company Information
  15. 6.3.2 Tiziana Life Sciences Plc Business Overview
  16. 6.3.3 Tiziana Life Sciences Plc High Affinity Nerve Growth Factor Receptor Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Tiziana Life Sciences Plc High Affinity Nerve Growth Factor Receptor Product Portfolio
  18. 6.3.5 Tiziana Life Sciences Plc Recent Developments
  19. 6.4 Sienna Biopharmaceuticals Inc
  20. 6.4.1 Sienna Biopharmaceuticals Inc Company Information
  21. 6.4.2 Sienna Biopharmaceuticals Inc Business Overview
  22. 6.4.3 Sienna Biopharmaceuticals Inc High Affinity Nerve Growth Factor Receptor Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Sienna Biopharmaceuticals Inc High Affinity Nerve Growth Factor Receptor Product Portfolio
  24. 6.4.5 Sienna Biopharmaceuticals Inc Recent Developments
  25. 6.5 Rottapharm Biotech Srl
  26. 6.5.1 Rottapharm Biotech Srl Company Information
  27. 6.5.2 Rottapharm Biotech Srl Business Overview
  28. 6.5.3 Rottapharm Biotech Srl High Affinity Nerve Growth Factor Receptor Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Rottapharm Biotech Srl High Affinity Nerve Growth Factor Receptor Product Portfolio
  30. 6.5.5 Rottapharm Biotech Srl Recent Developments
  31. 6.6 Proximagen Ltd
  32. 6.6.1 Proximagen Ltd Company Information
  33. 6.6.2 Proximagen Ltd Business Overview
  34. 6.6.3 Proximagen Ltd High Affinity Nerve Growth Factor Receptor Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Proximagen Ltd High Affinity Nerve Growth Factor Receptor Product Portfolio
  36. 6.6.5 Proximagen Ltd Recent Developments
  37. 6.7 Plexxikon Inc
  38. 6.7.1 Plexxikon Inc Company Information
  39. 6.7.2 Plexxikon Inc Business Overview
  40. 6.7.3 Plexxikon Inc High Affinity Nerve Growth Factor Receptor Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Plexxikon Inc High Affinity Nerve Growth Factor Receptor Product Portfolio
  42. 6.7.5 Plexxikon Inc Recent Developments
  43. 6.8 Nerviano Medical Sciences Srl
  44. 6.8.1 Nerviano Medical Sciences Srl Company Information
  45. 6.8.2 Nerviano Medical Sciences Srl Business Overview
  46. 6.8.3 Nerviano Medical Sciences Srl High Affinity Nerve Growth Factor Receptor Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Nerviano Medical Sciences Srl High Affinity Nerve Growth Factor Receptor Product Portfolio
  48. 6.8.5 Nerviano Medical Sciences Srl Recent Developments
  49. 6.9 Loxo Oncology Inc
  50. 6.9.1 Loxo Oncology Inc Company Information
  51. 6.9.2 Loxo Oncology Inc Business Overview
  52. 6.9.3 Loxo Oncology Inc High Affinity Nerve Growth Factor Receptor Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Loxo Oncology Inc High Affinity Nerve Growth Factor Receptor Product Portfolio
  54. 6.9.5 Loxo Oncology Inc Recent Developments
  55. 6.10 Ignyta Inc
  56. 6.10.1 Ignyta Inc Company Information
  57. 6.10.2 Ignyta Inc Business Overview
  58. 6.10.3 Ignyta Inc High Affinity Nerve Growth Factor Receptor Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Ignyta Inc High Affinity Nerve Growth Factor Receptor Product Portfolio
  60. 6.10.5 Ignyta Inc Recent Developments
  61. 6.11 Handok Inc
  62. 6.11.1 Handok Inc Company Information
  63. 6.11.2 Handok Inc Business Overview
  64. 6.11.3 Handok Inc High Affinity Nerve Growth Factor Receptor Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Handok Inc High Affinity Nerve Growth Factor Receptor Product Portfolio
  66. 6.11.5 Handok Inc Recent Developments
  67. 6.12 Genzyme Corp
  68. 6.12.1 Genzyme Corp Company Information
  69. 6.12.2 Genzyme Corp Business Overview
  70. 6.12.3 Genzyme Corp High Affinity Nerve Growth Factor Receptor Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Genzyme Corp High Affinity Nerve Growth Factor Receptor Product Portfolio
  72. 6.12.5 Genzyme Corp Recent Developments
  73. 6.13 Dompe Farmaceutici SpA
  74. 6.13.1 Dompe Farmaceutici SpA Company Information
  75. 6.13.2 Dompe Farmaceutici SpA Business Overview
  76. 6.13.3 Dompe Farmaceutici SpA High Affinity Nerve Growth Factor Receptor Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Dompe Farmaceutici SpA High Affinity Nerve Growth Factor Receptor Product Portfolio
  78. 6.13.5 Dompe Farmaceutici SpA Recent Developments
  79. 6.14 Daiichi Sankyo Co Ltd
  80. 6.14.1 Daiichi Sankyo Co Ltd Company Information
  81. 6.14.2 Daiichi Sankyo Co Ltd Business Overview
  82. 6.14.3 Daiichi Sankyo Co Ltd High Affinity Nerve Growth Factor Receptor Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Daiichi Sankyo Co Ltd High Affinity Nerve Growth Factor Receptor Product Portfolio
  84. 6.14.5 Daiichi Sankyo Co Ltd Recent Developments
  85. 6.15 Astellas Pharma Inc
  86. 6.15.1 Astellas Pharma Inc Company Information
  87. 6.15.2 Astellas Pharma Inc Business Overview
  88. 6.15.3 Astellas Pharma Inc High Affinity Nerve Growth Factor Receptor Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Astellas Pharma Inc High Affinity Nerve Growth Factor Receptor Product Portfolio
  90. 6.15.5 Astellas Pharma Inc Recent Developments
  91. 6.16 Array BioPharma Inc
  92. 6.16.1 Array BioPharma Inc Company Information
  93. 6.16.2 Array BioPharma Inc Business Overview
  94. 6.16.3 Array BioPharma Inc High Affinity Nerve Growth Factor Receptor Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Array BioPharma Inc High Affinity Nerve Growth Factor Receptor Product Portfolio
  96. 6.16.5 Array BioPharma Inc Recent Developments
7 North America
  1. 7.1 North America High Affinity Nerve Growth Factor Receptor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America High Affinity Nerve Growth Factor Receptor Market Size by Country (2021-2026)
  3. 7.3 North America High Affinity Nerve Growth Factor Receptor Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe High Affinity Nerve Growth Factor Receptor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe High Affinity Nerve Growth Factor Receptor Market Size by Country (2021-2026)
  3. 8.3 Europe High Affinity Nerve Growth Factor Receptor Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America High Affinity Nerve Growth Factor Receptor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America High Affinity Nerve Growth Factor Receptor Market Size by Country (2021-2026)
  3. 10.3 South America High Affinity Nerve Growth Factor Receptor Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst